과제정보
연구 과제 주관 기관 : Ministry of Health and Welfare
참고문헌
- Abu-Shakra, M., Buskila, D., and Shoenfeld, Y. (2003). Osteonecrosis in patients with SLE. Clin. Rev. Allergy Immunol. 25, 13-24 https://doi.org/10.1385/CRIAI:25:1:13
- Aksoy, M.C., Aksoy, D.Y., Haznedaroglu, I.C., Sayinalp, N., Kirazli, S., and Alpaslan, M. (2005). Enhanced tissue factor pathway inhibitor response as a defense mechanism against ongoing local microvascular events of Legg-Calve-Perthes disease. Pediatr. Hematol. Oncol. 22, 391-399 https://doi.org/10.1080/08880010590964273
-
Ameziane, N., Seguin, C., Borgel, D., Fumeron, F., Moatti, D., Alhenc-Gelas, M., Grandchamp, B., Aiach, M., Emmerich, J., and de Prost, D. (2002). The -33T
$\rightarrow$ C polymorphism in intron 7 of the TFPI gene influences the risk of venous thromboembolism, independently of the factor V Leiden and prothrombin mutations. Thromb. Haemost. 88, 195-199 https://doi.org/10.1055/s-0037-1613186 - Amini Nekoo, A., and Iles, D. (2008). Analysis of a T-287C polymorphism in the tissue factor pathway inhibitor gene and identification of a repressor element in the promoter. Thromb. Res. 121, 813-819 https://doi.org/10.1016/j.thromres.2007.08.012
- Amini-Nekoo, A., Futers, T.S., Moia, M., Mannucci, P.M., Grant, P.J., and Ariens, R.A. (2001). Analysis of the tissue factor pathway inhibitor gene and antigen levels in relation to venous thrombosis. Br. J. Haematol. 113, 537-543 https://doi.org/10.1046/j.1365-2141.2001.02752.x
- Assouline-Dayan, Y., Chang, C., Greenspan, A., Shoenfeld, Y., and Gershwin, M.E. (2002). Pathogenesis and natural history of osteonecrosis. Semin. Arthritis Rheum. 32, 94-124
- Atsumi, T., and Kuroki, Y. (1992). Role of impairment of blood supply of the femoral head in the pathogenesis of idiopathic osteonecrosis. Clin. Orthop. Relat. Res. 277, 22-30
- Bjorkman, A., Svensson, P.J., Hillarp, A., Burtscher, I.M., Runow, A., and Benoni, G. (2004). Factor V leiden and prothrombin gene mutation: risk factors for osteonecrosis of the femoral head in adults. Clin. Orthop. Relat. Res. 425, 168-172 https://doi.org/10.1097/00003086-200408000-00023
- Chang, J.D., Hur, M., Lee, S.S., Yoo, J.H., and Lee, K.M. (2008). Genetic background of nontraumatic osteonecrosis of the femoral head in the Korean population. Clin. Orthop. Relat. Res. 466, 1041-1046 https://doi.org/10.1007/s11999-008-0147-1
- Cruess, R.L. (1986). Osteonecrosis of bone. Current concepts as to etiology and pathogenesis. Clin. Orthop. Relat. Res. 208, 30-39
- Fisher, D.E. (1978). The role of fat embolism in the etiology of corticosteroid- induced avascular necrosis: clinical and experimental results. Clin. Orthop. Relat. Res. 130, 68-80
- Girard, T.J., Warren, L.A., Novotny, W.F., Likert, K.M., Brown, S.G., Miletich, J.P., and Broze, G.J., Jr. (1989). Functional significance of the Kunitz-type inhibitory domains of lipoproteinassociated coagulation inhibitor. Nature 338, 518-520 https://doi.org/10.1038/338518a0
- Girard, T.J., Eddy, R., Wesselschmidt, R.L., MacPhail, L.A., Likert, K.M., Byers, M.G., Shows, T.B., and Broze, G.J., Jr. (1991). Structure of the human lipoprotein-associated coagulation inhibitor gene. Intro/exon gene organization and localization of the gene to chromosome 2. J. Biol. Chem. 266, 5036-5041
- Glueck, C.J., Glueck, H.I., Welch, M., Freiberg, R., Tracy, T., Hamer, T., and Stroop, D. (1994). Familial idiopathic osteonecrosis mediated by familial hypofibrinolysis with high levels of plasminogen activator inhibitor. Thromb. Haemost. 71, 195-198
- Glueck, C.J., Freiberg, R., Glueck, H.I., Tracy, T., Stroop, D., and Wang, Y. (1995). Idiopathic osteonecrosis, hypofibrinolysis, high plasminogen activator inhibitor, high lipoprotein(a), and therapy with Stanozolol. Am. J. Hematol. 48, 213-220 https://doi.org/10.1002/ajh.2830480402
- Glueck, C.J., Brandt, G., Gruppo, R., Crawford, A., Roy, D., Tracy, T., Stroop, D., Wang, P., and Becker, A. (1997a). Resistance to activated protein C and Legg-Perthes disease. Clin. Orthop. Relat. Res. 338, 139-152 https://doi.org/10.1097/00003086-199705000-00021
- Glueck, C.J., Freiberg, R., Tracy, T., Stroop, D., and Wang, P. (1997b). Thrombophilia and hypofibrinolysis: pathophysiologies of osteonecrosis. Clin. Orthop. Relat. Res. 334, 43-56
- Glueck, C.J., Fontaine, R.N., Gruppo, R., Stroop, D., Sieve-Smith, L., Tracy, T., and Wang, P. (1999). The plasminogen activator inhibitor-1 gene, hypofibrinolysis, and osteonecrosis. Clin. Orthop. Relat. Res. 366, 133-146 https://doi.org/10.1097/00003086-199909000-00017
- Glueck, C.J., Freiberg, R.A., Fontaine, R.N., Tracy, T., and Wang, P. (2001). Hypofibrinolysis, thrombophilia, osteonecrosis. Clin. Orthop. Relat. Res. 386, 19-33 https://doi.org/10.1097/00003086-200105000-00004
- Gruppo, R., Glueck, C.J., McMahon, R.E., Bouquot, J., Rabinovich, B.A., Becker, A., Tracy, T., and Wang, P. (1996). The pathophysiology of alveolar osteonecrosis of the jaw: anticardiolipin antibodies, thrombophilia, and hypofibrinolysis. J. Lab. Clin. Med. 127, 481-488 https://doi.org/10.1016/S0022-2143(96)90065-7
- Gruppo, R., Glueck, C.J., Wall, E., Roy, D., and Wang, P. (1998). Legg-Perthes disease in three siblings, two heterozygous and one homozygous for the factor V Leiden mutation. J. Pediatr. 132, 885-888 https://doi.org/10.1016/S0022-3476(98)70326-9
- He, M., Wen, Z., He, X., Xiong, S., Liu, F., Xu, J., Li, J., Xie, Q., Jian, Z., Chen, F., et al. (2002). Observation on tissue factor pathway and some other coagulation parameters during the onset of acute cerebrocardiac thrombotic diseases. Thromb. Res. 107, 223-228 https://doi.org/10.1016/S0049-3848(02)00331-6
- Hirota, Y., Hirohata, T., Fukuda, K., Mori, M., Yanagawa, H., Ohno, Y., and Sugioka, Y. (1993). Association of alcohol intake, cigarette smoking, and occupational status with the risk of idiopathic osteonecrosis of the femoral head. Am. J. Epidemiol. 137, 530-538 https://doi.org/10.1093/oxfordjournals.aje.a116706
- Hong, J.M., Kim, T.H., Chae, S.C., Koo, K.H., Lee, Y.J., Park, E.K., Choi, J.Y., Ryoo, H. M., and Kim, S.Y. (2007). Association study of hypoxia inducible factor 1alpha (HIF1alpha) with osteonecrosis of femoral head in a Korean population. Osteoarthritis Cartilage 15, 688-694 https://doi.org/10.1016/j.joca.2006.12.007
- Jones, J.P., Jr. (1985). Fat embolism and osteonecrosis. Orthop. Clin. North Am. 16, 595-633
- Jones, J.P., Jr. (1999). Coagulopathies and osteonecrosis. Acta Orthop. Belg. 65, 5-8
- Jones, L.C., Mont, M.A., Le, T.B., Petri, M., Hungerford, D.S., Wang, P., and Glueck, C.J. (2003). Procoagulants and osteonecrosis. J. Rheumatol. 30, 783-791
- Kim, S.Y., Suh, J.S., Park, E.K., Jung, W.B., Kim, J.W., Koo, K.H., and Kim, C.Y. (2003). Factor V Leiden gene mutation in femoral head osteonecrosis. J. Korean Ortho. Res. Soc. 6, 259-264
- Kim, T.H., Hong, J.M., Park, E.K., and Kim, S.Y. (2007). Peroxisome proliferator-activated receptor-gamma gene polymorphisms are not associated with osteonecrosis of the femoral head in the Korean population. Mol. Cells 24, 388-393
- Lindahl, A.K. (1997). Tissue factor pathway inhibitor: from unknown coagulation inhibitor to major antithrombotic principle. Cardiovasc. Res. 33, 286-291 https://doi.org/10.1016/S0008-6363(96)00208-8
- Lwaleed, B.A., and Bass, P.S. (2006). Tissue factor pathway inhibitor: structure, biology and involvement in disease. J. Pathol. 208, 327-339 https://doi.org/10.1002/path.1871
- Miyanishi, K., Yamamoto, T., Irisa, T., Noguchi, Y., Sugioka, Y., and Iwamoto, Y. (1999). Increased level of apolipoprotein B/apolipoprotein A1 ratio as a potential risk for osteonecrosis. Ann. Rheum. Dis. 58, 514-516 https://doi.org/10.1136/ard.58.8.514
- Miyata, T., Sakata, T., Kumeda, K., Uchida, K., Tsushima, M., Fujimura, H., Kawasaki, T., and Kato, H. (1998). C-399T polymorphism in the promoter region of human tissue factor pathway inhibitor (TFPI) gene does not change the plasma TFPI antigen level and does not cause venous thrombosis. Thromb. Haemost. 80, 345-346 https://doi.org/10.1055/s-0037-1615202
- Moatti, D., Seknadji, P., Galand, C., Poirier, O., Fumeron, F., Desprez, S., Garbarz, M., Dhermy, D., Arveiler, D., Evans, A., et al. (1999). Polymorphisms of the tissue factor pathway inhibitor (TFPI) gene in patients with acute coronary syndromes and in healthy subjects : impact of the V264M substitution on plasma levels of TFPI. Arterioscler. Thromb. Vasc. Biol. 19, 862-869 https://doi.org/10.1161/01.ATV.19.4.862
- Moatti, D., Haidar, B., Fumeron, F., Gauci, L., Boudvillain, O.,Seknadji, P., Olliver, V., Aumont, M.C., and de Prost, D. (2000). A new T-287C polymorphism in the 5' regulatory region of the tissue factor pathway inhibitor gene. Association study of the T-287C and C-399T polymorphisms with coronary artery disease and plasma TFPI levels. Thromb. Haemost. 84, 244-249 https://doi.org/10.1055/s-0037-1614003
- Mont, M.A., Ulrich, S.D., and Seyler, T.M. (2007). Role of thrombotic and fibrinolytic alterations in the pathogenesis and treatment of osteonecrosis. J. Rheumatol. 34, 466-468 https://doi.org/10.1093/rheumatology/34.5.466
- Nilsson, I.M., Krook, H., Sternby, N.H., Soderberg, E., and Soderstrom, N. (1961). Severe thrombotic disease in a young man with bone marrow and skeletal changes and with a high content of an inhibitor in the fibrinolytic system. Acta Med. Scand. 169, 323-337 https://doi.org/10.1111/j.0954-6820.1961.tb07838.x
- Qin, Z.S., Niu, T., and Liu, J.S. (2002). Partition-ligation-expectation- maximization algorithm for haplotype inference with singlenucleotide polymorphisms. Am. J. Hum. Genet. 71, 1242-1247 https://doi.org/10.1086/344207
- Rapaport, S.I., and Rao, L.V. (1995). The tissue factor pathway: how it has become a "prima ballerina". Thromb. Haemost. 74, 7-17
- Saito, S., Ohzono, K., and Ono, K. (1992). Early arteriopathy and postulated pathogenesis of osteonecrosis of the femoral head. The intracapital arterioles. Clin. Orthop. Relat. Res. 277, 98-110
- Van Veldhuizen, P.J., Neff, J., Murphey, M.D., Bodensteiner, D., and Skikne, B.S. (1993). Decreased fibrinolytic potential in patients with idiopathic avascular necrosis and transient osteoporosis of the hip. Am. J. Hematol. 44, 243-248 https://doi.org/10.1002/ajh.2830440405
- Wang, Y., Li, Y., Mao, K., Li, J., Cui, Q., and Wang, G.J. (2003). Alcohol-induced adipogenesis in bone and marrow: a possible mechanism for osteonecrosis. Clin. Orthop. Relat. Res. 410, 213-224 https://doi.org/10.1097/01.blo.0000063602.67412.83
- Wermes, C., Bergmann, F., Reller, B., and Sykora, K.W. (1999). Severe protein C deficiency and aseptic osteonecrosis of the hip joint: a case report. Eur. J. Pediatr. 158(Suppl. 3), S159-161 https://doi.org/10.1007/PL00014345
-
Zalavras, C.G., Malizos, K.N., Dokou, E., and Vartholomatos, G. (2002). The 677C
$\rightarrow$ T mutation of the methylene-tetrahydrofolate reductase gene in the pathogenesis of osteonecrosis of the femoral head. Haematologica 87, 111-112 - Zalavras, C.G., Vartholomatos, G., Dokou, E., and Malizos, K.N. (2004). Genetic background of osteonecrosis: associated with thrombophilic mutations? Clin. Orthop. Relat. Res. 422, 251-255 https://doi.org/10.1097/01.blo.0000127921.13253.e3